LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4

por Wu, Xingcheng, Xiao, Yu, Zhou, Yi, Zhou, Zhien, Yan, Weigang
Publicado 2019

Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes: A case report

por Zheng, Guoyang, Li, Hanzhong, Li, Ji, Zhang, Xuebin, Zhang, Yushi, Wu, Xingcheng
Publicado 2017

A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma

por Zhou, Jingmin, Liu, Guanghua, Wu, Xingcheng, Zhou, Zhien, Li, Jialin, Ji, Zhigang
Publicado 2021

Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy

por Chen, Yuliang, Zhou, Zhien, Zhou, Yi, Wu, Xingcheng, Xiao, Yu, Ji, Zhigang, Li, Hanzhong, Yan, Weigang
Publicado 2021

The direct prognosis comparison of (125)I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer

por Liang, Zhen, Yuliang, Chen, Zhu, Ming, Zhou, Yi, Wu, Xingcheng, Li, Hanzhong, Fan, Bu, Zhou, Zhien, Yan, Weigang
Publicado 2023

Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review

por Zhao, Bingbin, Zhou, Yi, Zhao, Yi, Zhao, Yumo, Wu, Xingcheng, Bi, Yalan, Luo, Yufeng, Ji, Zhigang, Rong, Shi
Publicado 2018